|
1
|
Maris JM and Matthay KK: Molecular biology
of neuroblastoma. J Clin Oncol. 17:2264–2279. 1999.PubMed/NCBI
|
|
2
|
Combaret V, Delattre O, Bénard J and
Favrot MC: Biological markers for the prognosis of neuroblastoma:
Proposal of a method of analysis. Bull Cancer. 85:262–266. 1998.(In
French). PubMed/NCBI
|
|
3
|
Park JR, Eggert A and Caron H:
Neuroblastoma: Biology, prognosis, and treatment. Hematol Oncol
Clin North Am. 24:65–86. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sawadogo WR, Schumacher M, Teiten MH,
Dicato M and Diederich M: Traditional West African pharmacopeia,
plants and derived compounds for cancer therapy. Biochem Pharmacol.
84:1225–1240. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tan W, Lu J, Huang M, Li Y, Chen M, Wu G,
Gong J, Zhong Z, Xu Z, Dang Y, et al: Anti-cancer natural products
isolated from Chinese medicinal herbs. Chin Med. 6:272011.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jo H, Loison F, Hattori H, Silberstein LE,
Yu H and Luo HR: Natural product Celastrol destabilizes tubulin
heterodimer and facilitates mitotic cell death triggered by
microtubule-targeting anti-cancer drugs. PLoS One. 5:e103182010.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Desai AG, Qazi GN, Ganju RK, El-Tamer M,
Singh J, Saxena AK, Bedi YS, Taneja SC and Bhat HK: Medicinal
plants and cancer chemoprevention. Curr Drug Metab. 9:581–591.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Konkimalla VB and Efferth T: Anti-cancer
natural product library from traditional Chinese medicine. Comb
Chem High Throughput Screen. 11:7–15. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mukherjee AK, Basu S, Sarkar N and Ghosh
AC: Advances in cancer therapy with plant based natural products.
Curr Med Chem. 8:1467–1486. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang LQ, Guo FJ, Wang SC and Li YM: A new
triterpenoid tetrasaccharide from the root of Scrophularia
ningpoensis. Yao Xue Xue Bao. 47:1358–1362. 2012.
|
|
11
|
Chen C, Duan LN, Zhou XL, Chen BL and Fu
CX: Molecular authentication of geo-authentic Scrophularia
ningpoensis. J Zhejiang Univ Sci B. 12:393–398. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Huang CG, Shang YJ, Zhang J, Zhang JR, Li
WJ and Jiao BH: Hypouricemic effects of phenylpropanoid glycosides
acteoside of Scrophularia ningpoensis on serum uric acid levels in
potassium oxonate-pretreated mice. Am J Chin Med. 36:149–157. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang S, Zheng Z, Weng Y, Yu Y, Zhang D,
Fan W, Dai R and Hu Z: Angiogenesis and anti-angiogenesis activity
of Chinese medicinal herbal extracts. Life Sci. 74:2467–2478. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ahmad M, Muhammad N, Mehjabeen, Jahan N,
Alam SM, Ahmad M and Obaidullah: Biological screening of
Scrophularia nodosa extract and its fractions. Pak J Pharm Sci.
25:307–313. 2012.PubMed/NCBI
|
|
15
|
García D, Fernández A, Sáenz T and Ahumada
C: Anti-inflammatory effects of different extracts and harpagoside
isolated from Scrophularia frutescens L. Farmaco. 51:443–446.
1996.
|
|
16
|
Giner RM, Villalba ML, Recio MC, Máñez S,
Cerdá-Nicolás M and Ríos J: Anti-inflammatory glycoterpenoids from
Scrophularia auriculata. Eur J Pharmacol. 389:243–252. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fernández MA, Sáenz MT and García MD:
Anti-inflammatory activity in rats and mice of phenolic acids
isolated from Scrophularia frutescens. J Pharm Pharmacol.
50:1183–1186. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Giessrigl B, Yazici G, Teichmann M, Kopf
S, Ghassemi S, Atanasov AG, Dirsch VM, Grusch M, Jäger W, Ozmen A,
et al: Effects of Scrophularia extracts on tumor cell
proliferation, death and intravasation through lymphoendothelial
cell barriers. Int J Oncol. 40:2063–2074. 2012.PubMed/NCBI
|
|
19
|
Ardeshiry Lajimi A, Rezaie-Tavirani M,
Mortazavi SA, Barzegar M, Moghadamnia SH and Rezaee MB: Study of
anti-cancer property of Scrophularia striata extract on the human
astrocytoma cell line (1321). Iran J Pharm Res. 9:403–410.
2010.PubMed/NCBI
|
|
20
|
Qu B, Al-Ansary D, Kummerow C, Hoth M and
Schwarz EC: ORAI-mediated calcium influx in T cell proliferation,
apoptosis and tolerance. Cell Calcium. 50:261–269. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu H, Hughes JD, Rollins S, Chen B and
Perkins E: Calcium entry via ORAI1 regulates glioblastoma cell
proliferation and apoptosis. Exp Mol Pathol. 91:753–760. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Huang W, Lu C, Wu Y, Ouyang S and Chen Y:
T-type calcium channel antagonists, mibefradil and NNC-55-0396
inhibit cell proliferation and induce cell apoptosis in leukemia
cell lines. J Exp Clin Cancer Res. 34:542015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Choi DL, Jang SJ, Cho S, Choi HE, Rim HK,
Lee KT and Lee JY: Inhibition of cellular proliferation and
induction of apoptosis in human lung adenocarcinoma A549 cells by
T-type calcium channel antagonist. Bioorg Med Chem Lett.
24:1565–1570. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ohkubo T and Yamazaki J: T-type
voltage-activated calcium channel Cav3.1, but not Cav3.2, is
involved in the inhibition of proliferation and apoptosis in MCF-7
human breast cancer cells. Int J Oncol. 41:267–275. 2012.PubMed/NCBI
|
|
25
|
Zhu T, Zhang L, Ling S, Duan J, Qian F, Li
Y and Xu JW: Scropolioside B inhibits IL-1β and cytokines
expression through NF-κB and inflammasome NLRP3 pathways. Mediators
Inflamm. 2014:8190532014. View Article : Google Scholar
|
|
26
|
Murphy DM, Buckley PG, Bryan K, Das S,
Alcock L, Foley NH, Prenter S, Bray I, Watters KM, Higgins D, et
al: Global MYCN transcription factor binding analysis in
neuroblastoma reveals association with distinct E-box motifs and
regions of DNA hypermethylation. PLoS One. 4:e81542009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chan HS, Gallie BL, DeBoer G, Haddad G,
Ikegaki N, Dimitroulakos J, Yeger H and Ling V: MYCN protein
expression as a predictor of neuroblastoma prognosis. Clin Cancer
Res. 3:1699–1706. 1997.
|
|
28
|
Tonini GP, Boni L, Pession A, Rogers D,
Iolascon A, Basso G, Cordero di Montezemolo L, Casale F, Pession A,
Perri P, et al: MYCN oncogene amplification in neuroblastoma is
associated with worse prognosis, except in stage 4s: The Italian
experience with 295 children. J Clin Oncol. 15:85–93.
1997.PubMed/NCBI
|
|
29
|
Gogolin S, Dreidax D, Becker G, Ehemann V,
Schwab M and Westermann F: MYCN/MYC-mediated drug resistance
mechanisms in neuroblastoma. Int J Clin Pharmacol Ther. 48:489–491.
2010. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Guo RW and Huang L: New insights into the
activation mechanism of store-operated calcium channels: Roles of
STIM and Orai. J Zhejiang Univ Sci B. 9:591–601. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Peel SE, Liu B and Hall IP: ORAI and
store-operated calcium influx in human airway smooth muscle cells.
Am J Respir Cell Mol Biol. 38:744–749. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hewavitharana T, Deng X, Soboloff J and
Gill DL: Role of STIM and Orai proteins in the store-operated
calcium signaling pathway. Cell Calcium. 42:173–182. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Vig M, Beck A, Billingsley JM, Lis A,
Parvez S, Peinelt C, Koomoa DL, Soboloff J, Gill DL, Fleig A, et
al: CRACM1 multimers form the ion-selective pore of the CRAC
channel. Curr Biol. 16:2073–2079. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Peinelt C, Vig M, Koomoa DL, Beck A,
Nadler MJ, Koblan-Huberson M, Lis A, Fleig A, Penner R and Kinet
JP: Amplification of CRAC current by STIM1 and CRACM1 (Orai1). Nat
Cell Biol. 8:771–773. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Vig M, Peinelt C, Beck A, Koomoa DL, Rabah
D, Koblan-Huberson M, Kraft S, Turner H, Fleig A, Penner R, et al:
CRACM1 is a plasma membrane protein essential for store-operated
Ca2+ entry. Science. 312:1220–1223. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Carafoli E and Guerini D: Molecular and
cellular biology of plasma membrane calcium ATPase. Trends
Cardiovasc Med. 3:177–184. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Newton T, Black JP, Butler J, Lee AG, Chad
J and East JM: Sarco/endoplasmic-reticulum calcium ATPase SERCA1 is
maintained in the endoplasmic reticulum by a retrieval signal
located between residues 1 and 211. Biochem J. 371:775–782. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Martínez F, Uribe A, Espinosa-García MT,
Flores-Herrera O, García-Pérez C and Milán R: Calcium modulates the
ATP and ADP hydrolysis in human placental mitochondria. Int J
Biochem Cell Biol. 34:992–1003. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Tanaka J, Kono Y, Shimahara Y, Sato T,
Jones RT, Cowley RA and Trump BF: A study of oxidative
phosphorylative activity and calcium-induced respiration of rat
liver mitochondria following living Escherichia coli injection. Adv
Shock Res. 7:77–90. 1982.PubMed/NCBI
|
|
40
|
García-Sancho J: The coupling of plasma
membrane calcium entry to calcium uptake by endoplasmic reticulum
and mitochondria. J Physiol. 592:261–268. 2014. View Article : Google Scholar :
|
|
41
|
Santo-Domingo J and Demaurex N: Calcium
uptake mechanisms of mitochondria. Biochim Biophys Acta.
1797:907–912. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Patergnani S, Suski JM, Agnoletto C,
Bononi A, Bonora M, De Marchi E, Giorgi C, Marchi S, Missiroli S,
Poletti F, et al: Calcium signaling around Mitochondria Associated
Membranes (MAMs). Cell Commun Signal. 9:192011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Smaili SS, Hsu YT, Carvalho AC, Rosenstock
TR, Sharpe JC and Youle RJ: Mitochondria, calcium and pro-apoptotic
proteins as mediators in cell death signaling. Braz J Med Biol Res.
36:183–190. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Ermak G and Davies KJ: Calcium and
oxidative stress: From cell signaling to cell death. Mol Immunol.
38:713–721. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Lewis A, Hayashi T, Su TP and Betenbaugh
MJ: Bcl-2 family in inter-organelle modulation of calcium
signaling; roles in bioen-ergetics and cell survival. J Bioenerg
Biomembr. 46:1–15. 2014. View Article : Google Scholar
|
|
46
|
Annunziata I and d'Azzo A: Interorganellar
membrane microdomains: Dynamic platforms in the control of calcium
signaling and apoptosis. Cells. 2:574–590. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Krebs J, Agellon LB and Michalak M: Ca(2+)
homeostasis and endoplasmic reticulum (ER) stress: An integrated
view of calcium signaling. Biochem Biophys Res Commun. 460:114–121.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Balaban RS: The role of Ca(2+) signaling
in the coordination of mitochondrial ATP production with cardiac
work. Biochim Biophys Acta. 1787:1334–1341. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Malli R, Frieden M, Trenker M and Graier
WF: The role of mitochondria for Ca2+ refilling of the
endoplasmic reticulum. J Biol Chem. 280:12114–12122. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Dahlem YA, Wolf G, Siemen D and Horn TF:
Combined modulation of the mitochondrial ATP-dependent potassium
channel and the permeability transition pore causes prolongation of
the biphasic calcium dynamics. Cell Calcium. 39:387–400. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Deniaud A, Sharaf el Dein O, Maillier E,
Poncet D, Kroemer G, Lemaire C and Brenner C: Endoplasmic reticulum
stress induces calcium-dependent permeability transition,
mitochondrial outer membrane permeabilization and apoptosis.
Oncogene. 27:285–299. 2008. View Article : Google Scholar
|
|
52
|
Ma X, Tian X, Huang X, Yan F and Qiao D:
Resveratrol-induced mitochondrial dysfunction and apoptosis are
associated with Ca2+ and mCICR-mediated MPT activation
in HepG2 cells. Mol Cell Biochem. 302:99–109. 2007. View Article : Google Scholar : PubMed/NCBI
|
